Patents by Inventor Pasi Kankaanpaa

Pasi Kankaanpaa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230201818
    Abstract: According to an example aspect of the present invention, there is provided a method, comprising: providing a wearable electronic device that is configured to be worn by a user of a laboratory device; by means of the wearable device, retrieving user data that is specific to said user; and on the basis of the retrieved user data, providing a functionality for control of the laboratory device.
    Type: Application
    Filed: December 29, 2022
    Publication date: June 29, 2023
    Inventors: Pasi Kankaanpää, Ville Hintikka, Kari Salivaara
  • Publication number: 20180237602
    Abstract: Functionalized substrates with properties that can control cell-substrate interactions, induce cellular processes and decisions by means of passive and active control to enhance cell proliferation, cell migration and wound healing are provided. By including a sensing electrode on the substrate, it is possible to measure the metabolites of cells or follow the migration of additives like drug molecules in real-time. The present technology provides a new cell culture and imaging platform composed of a transparent and chemically and topographically customized latex film with electrodes that enable real-time measurement of e.g. pH and ion concentration in the cell medium as well as the metabolic states of the cells.
    Type: Application
    Filed: August 26, 2016
    Publication date: August 23, 2018
    Inventors: Petri Ihalainen, Anni Määttänen, Sven Rosqvist, Jouko Peltonen, John Eriksson, Erik Niemelä, Arun Venu, Pasi Kankaanpää, Hend Abdelkader, Fang Cheng
  • Patent number: 7544513
    Abstract: The present invention provides an assay, suitable for neonatal screening of hemoglobinopathies by quantitatively determining the presence of at least one pair of hemoglobin (Hb) variants, determining the ratio between the signals obtained from each variant; and, based on that ratio, determining whether the tested subject is afflicted or not.
    Type: Grant
    Filed: September 22, 2004
    Date of Patent: June 9, 2009
    Assignee: Wallac Oy
    Inventors: Kaj Blomberg, Pasi Kankaanpaa, Thomas Campbell
  • Publication number: 20050118654
    Abstract: The present invention provides an assay, suitable for neonatal screening of hemoglobinopathies by quantitatively determining the presence of at least one pair of hemoglobin (Hb) variants, determining the ratio between the signals obtained from each variant; and, based on that ratio, determining whether the tested subject is afflicted or not.
    Type: Application
    Filed: September 22, 2004
    Publication date: June 2, 2005
    Applicant: WALLAC OY
    Inventors: Kaj Blomberg, Pasi Kankaanpaa, Thomas Campbell